康众医疗2025年净利亏损709.98万元

Core Viewpoint - Kangzhong Medical (688607) reported a revenue of 321 million yuan for the year 2025, reflecting a year-on-year growth of 7.52%, but the net profit turned negative at -7.1 million yuan, indicating a shift from profit to loss [1] Financial Performance - The company achieved an operating income of 321 million yuan in 2025, which is a 7.52% increase compared to the previous year [1] - The net profit for the year was -7.1 million yuan, marking a transition from profit to loss year-on-year [1] Reasons for Profit Decline - The decline in net profit is attributed to intensified industry competition, leading the company to adjust its pricing strategy to maintain market competitiveness [1] - The cost structure remained relatively rigid, and the adjustments in costs lagged behind the changes in sales prices, resulting in a decrease in gross profit margin compared to the previous year [1] Strategic Responses - The company is actively responding to external market challenges by increasing research and development investments, accelerating the implementation of R&D projects, and enhancing product competitiveness [1] - A new subsidiary was established during the reporting period, contributing to the overall increase in expenses [1] Credit Impairment - The company recognized credit impairment losses based on prudent principles due to litigation matters related to accounts receivable from certain clients, in accordance with relevant accounting standards [1]